Authors: Bart Jones August 27, 2022 Newsday Some medical experts on Long Island are disputing a new study that said Paxlovid did not help relieve COVID-19 symptoms in people under 65. Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, […]
Authors: Arielle Dreher Axios September 2, 2022 Paxlovid, once hailed as a “game-changer” for its ability to treat COVID-19 infections at home, is becoming one of the pandemic’s biggest enigmas. The intrigue: There’s growing concern about the link between Pfizer’s antiviral pill and COVID rebound, in which patients test positive or have symptoms days after a […]
Authors: Wire servicesJune 21, 2022 Individuals who received two doses of a COVID-19 vaccine have been linked with negative protection against the disease, scientists say in a study analyzing the Omicron wave in Qatar. The research also finds a previous infection without vaccination offers near 50 percent immunity, Published in the New England Journal of Medicine on June 15, the research examined the […]
An Italian review of COVID studies found that boosters restore vaccine effectiveness against omicron initially, but that protection falls off quickly Authors: NBC News July 8, 2022 COVID booster shots appear to be less than 20% effective against infection with the omicron variant of the virus just a few months after the booster is given, a new […]
Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]
Authors: Damian D. Guerra, Daniel J. Guerra doi: https://doi.org/10.1101/2021.05.18.21257385 Abstract Background Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission. Because COVID-19 can spread via respired droplets, many states have mandated mask use in public settings. Randomized control trials have not clearly demonstrated mask efficacy against respiratory viruses, and observational studies conflict on whether mask use predicts lower […]
Authors: Enrico Trigoso The Epoch Times June 3, 2022 During the Covid-19 pandemic, school and university administrators have dogmatically, and in many cases forcefully implemented mask and vaccine mandates with the intention to prevent the spread of SARS-CoV2, however, these policies haven’t had much effect, according to recent peer-reviewed studies. A research paper published on May 18 underscores the deficiencies […]
BAuthors: ALEXANDER TIN JUNE 2, 2022 As COVID-19 cases began to accelerate again this spring, federal data suggests the rate of breakthrough COVID infections in April was worse in boosted Americans compared to unboosted Americans — though rates of deaths and hospitalizations remained the lowest among the boosted. The new data do not mean booster shots are somehow increasing the risk. Ongoing […]
Authors: Jack Phillips via The Epoch Times, JUN 01, 2022 Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday. “We haven’t yet seen anybody who has returned with symptoms needing to go […]
Authors: Benjamin Ryan Published April 29, 2022 NBC Health Pfizer’s antiviral pills are highly effective at keeping people with Covid out of the hospital, but there are growing reports that, in rare cases, patients treated for the coronavirus with Paxlovid can experience a second round of the disease shortly after recovering. Infectious disease experts stress that cases […]